Multiple system atrophy: current and future approaches to management
Multiple system atrophy (MSA) is a rare neurodegenerative disorder without any effective treatment in slowing or stopping disease progression. It is characterized by poor levodopa responsive Parkinsonism, cerebellar ataxia, pyramidal signs and autonomic failure in any combination. Current therapeuti...
Main Authors: | Olivier Flabeau, Wassilios G. Meissner, François Tison |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-07-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285610375328 |
Similar Items
-
Multiple system atrophy: A prototypical synucleinopathy for disease-modifying therapeutic strategies
by: Pierre-Olivier Fernagut, et al.
Published: (2014-07-01) -
Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study
by: Alexandra Foubert-Samier, et al.
Published: (2020-06-01) -
Age and Gender Differences in Cardiovascular Autonomic Failure in the Transgenic PLP-syn Mouse, a Model of Multiple System Atrophy
by: Marc Kermorgant, et al.
Published: (2022-06-01) -
Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease
by: Annamaria Vallelunga, et al.
Published: (2021-07-01) -
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy
by: Miguel Lopez-Cuina, et al.
Published: (2018-10-01)